Biotron Limited (BIT.AX)
AUD 0.02
(-5.88%)
AUD 0.02
(-5.88%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.56 Million | -3.29 Million | -2.43 Million | -3.4 Million | -3.08 Million | -1.49 Million |
| Net Income | -3.43 Million | -3.49 Million | -2.78 Million | -3.19 Million | -3.57 Million | -1.61 Million |
| Depreciation & Amortization | 40.49 Thousand | 43.34 Thousand | 45.25 Thousand | 47.33 Thousand | 50.11 Thousand | 12.46 Thousand |
| Deferred income taxes | - | - | 96.99 Thousand | -544.42 Thousand | -50.67 Thousand | - |
| Stock-based compensation | - | - | 10.58 Thousand | 84.33 Thousand | 74.08 Thousand | - |
| Change in working capital | -183.46 Thousand | 121.72 Thousand | 208.11 Thousand | -358.23 Thousand | 349.79 Thousand | 62.84 Thousand |
| Other non-cash items | 311.77 Thousand | 37.66 Thousand | -15.91 Thousand | 557.73 Thousand | 70.81 Thousand | 38.6 Thousand |
| Investing Cash Flow | - | - | - | -5723.00 | - | -52.88 Thousand |
| Investments in PPE | -4.00 | - | - | -5723.00 | - | -40.93 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -11.94 Thousand |
| Financing Cash Flow | -22.62 Thousand | 5.53 Million | -33.17 Thousand | -36.95 Thousand | 5 Million | 5.74 Million |
| Debt repayment | - | -39.9 Thousand | -33.17 Thousand | -36.95 Thousand | -32.97 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -427.8 Thousand | - | - | -275.42 Thousand | -291.67 Thousand |
| Common Stock Issuance | 19.83 Thousand | 5.57 Million | - | - | 5.03 Million | 5.74 Million |
| Other Financing Activities | -42.45 Thousand | 5.53 Million | -33.17 Thousand | -36.95 Thousand | 5 Million | 292.17 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -219.84 Thousand | 147.67 Thousand | 198.08 Thousand | -365.41 Thousand | 123.64 Thousand | 63.39 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 36.37 Thousand | -25.95 Thousand | 10.03 Thousand | 7178.00 | 226.14 Thousand | -556.00 |
| Cash at beginning of period | 3.98 Million | 1.74 Million | 4.21 Million | 7.66 Million | 5.73 Million | 1.54 Million |
| Cash at end of period | 393.19 Thousand | 3.98 Million | 1.74 Million | 4.21 Million | 7.66 Million | 5.73 Million |
| Capital Expenditure | -4.00 | - | - | -5723.00 | - | -40.93 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 9.00 |
| Net cash flow / Change in cash | -3.59 Million | 2.24 Million | -2.46 Million | -3.45 Million | 1.92 Million | 4.19 Million |
| Free Cash Flow | -3.56 Million | -3.29 Million | -2.43 Million | -3.41 Million | -3.08 Million | -1.53 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.43 Million | -2.11 Million | -1.32 Million | -2.69 Million | -3.49 Million | -793.58 Thousand |
| Depreciation & Amortization | 40.49 Thousand | 18.79 Thousand | 21.7 Thousand | 20.82 Thousand | 43.34 Thousand | 22.51 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -183.46 Thousand | - | - | -25.95 Thousand | 121.72 Thousand | - |
| Other non-cash items | 311.77 Thousand | 1.82 Million | -1.91 Million | 251.94 Thousand | 37.66 Thousand | -5869.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -22.62 Thousand | -21 Thousand | -1615.00 | -19.39 Thousand | 5.53 Million | 5.55 Million |
| Debt repayment | - | - | -21.45 Thousand | - | -39.9 Thousand | -19.78 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -427.8 Thousand | - |
| Common Stock Issuance | 19.83 Thousand | - | 19.83 Thousand | 731.00 | 5.57 Million | 5.57 Million |
| Other Financing Activities | - | - | 19.83 Thousand | -19.39 Thousand | 5.53 Million | 5.57 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -219.84 Thousand | - | - | - | 147.67 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 36.37 Thousand | - | - | -25.95 Thousand | -25.95 Thousand | - |
| Cash at beginning of period | 3.98 Million | 721.68 Thousand | 3.98 Million | 6.47 Million | 1.74 Million | 1.74 Million |
| Cash at end of period | 393.19 Thousand | 393.19 Thousand | 721.68 Thousand | 3.98 Million | 3.98 Million | 6.47 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.59 Million | -328.48 Thousand | -3.26 Million | -2.48 Million | 2.24 Million | 4.73 Million |
| Free Cash Flow | -3.56 Million | -307.47 Thousand | -3.26 Million | -2.46 Million | -3.29 Million | -821.97 Thousand |
PRG
MEDICAPQ
9325
605339
TRS
ATNFW